TY - JOUR
T1 - Can trials of physical treatments be blinded? The example of transcutaneous electrical nerve stimulation for chronic pain
AU - Deyo, R. A.
AU - Walsh, N. E.
AU - Schoenfeld, L. S.
AU - Ramamurthy, S.
PY - 1990
Y1 - 1990
N2 - Therapeutic trials often attempt to 'blind' patient and investigator to the true nature of treatments received, reducing the influences of conscious or subconscious prejudices. In drug trials, this is accomplished with placebo tablets, but blinding in trials of physical treatments is more problematic. This issue arose in a clinical trial of transcutaneous eectrical nerve stimulation (TENS) for patients with chronic low back pain. Several study design features were incorporated to promote blinding: use of sham TENS units visually identical with real units, exclusion of potential subjects with previous TENS experience, avoidance of a crossover design and use of identical visit frequency, instructions and modifications in electrode placement. Subjects were asked not to discuss treatments with the clinicians who performed outcome assessments. Both patients and clinicians were asked to guess actual treatment assignments at the trial's end. Every patient in the true TENS group believed the unit was functioning properly, but the degree of certainty varied. In the sham TENS group, 84% also believed they had functioning units, but their certainty was significantly less than in the active treatment group. Differences in patient perceptions did not affect compliance, as the two groups had similar dropout rates, appointment compliance, days of TENS use and daily duration of TENS use. Clinicians guessed treatments correctly 61% of the time (as opposed to 50% expected by chance), again suggesting partial success in blinding. These efforts at blinding may partly explain the negative trial results for TENS efficacy. We conclude that complete blinding is difficult to achieve because of sensory difference in treatment and unintended communication between patient and examiner. Nonetheless, trials of physical treatments can achieve partial blinding with the techniques described here, and the success of blinding can be assessed with simple questions at study completion.
AB - Therapeutic trials often attempt to 'blind' patient and investigator to the true nature of treatments received, reducing the influences of conscious or subconscious prejudices. In drug trials, this is accomplished with placebo tablets, but blinding in trials of physical treatments is more problematic. This issue arose in a clinical trial of transcutaneous eectrical nerve stimulation (TENS) for patients with chronic low back pain. Several study design features were incorporated to promote blinding: use of sham TENS units visually identical with real units, exclusion of potential subjects with previous TENS experience, avoidance of a crossover design and use of identical visit frequency, instructions and modifications in electrode placement. Subjects were asked not to discuss treatments with the clinicians who performed outcome assessments. Both patients and clinicians were asked to guess actual treatment assignments at the trial's end. Every patient in the true TENS group believed the unit was functioning properly, but the degree of certainty varied. In the sham TENS group, 84% also believed they had functioning units, but their certainty was significantly less than in the active treatment group. Differences in patient perceptions did not affect compliance, as the two groups had similar dropout rates, appointment compliance, days of TENS use and daily duration of TENS use. Clinicians guessed treatments correctly 61% of the time (as opposed to 50% expected by chance), again suggesting partial success in blinding. These efforts at blinding may partly explain the negative trial results for TENS efficacy. We conclude that complete blinding is difficult to achieve because of sensory difference in treatment and unintended communication between patient and examiner. Nonetheless, trials of physical treatments can achieve partial blinding with the techniques described here, and the success of blinding can be assessed with simple questions at study completion.
KW - Blinding
KW - Compliance
KW - Trials
UR - http://www.scopus.com/inward/record.url?scp=0025388444&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025388444&partnerID=8YFLogxK
U2 - 10.1097/00002060-199002000-00003
DO - 10.1097/00002060-199002000-00003
M3 - Article
C2 - 2137345
AN - SCOPUS:0025388444
SN - 0894-9115
VL - 69
SP - 6
EP - 10
JO - American Journal of Physical Medicine and Rehabilitation
JF - American Journal of Physical Medicine and Rehabilitation
IS - 1
ER -